Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death

Immunity

Volumn 11, Issue 3, 1999, Pages 281-288

  Van Parijs, Luk ^a   Refaeli, Yosef ^b   Lord, James D ^c   Nelson, Brad H ^c   Abbas, Abul K ^b   Baltimore, David ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL DEATH; CELL SURVIVAL; GENE TRANSFER; GROWTH REGULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RETROVIRUS; T LYMPHOCYTE ACTIVATION;

EID: 0033199317     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80103-X     Document Type: Article

References (50)

1. Adams, J.M., and Cory, S. (1998). The Bcl-2 protein family: Arbiters of cell survival. Science 281, 1322-1326.
2. Ahmed, N.N., Grimes, H.L., Bellacosa, A., Chan, T.O., and Tsichlis, P.N., (1997). Transduction of interleukin-2 anti-apoptotic and proliferative signals via Akt protein kinase. Proc. Natl. Acad. Sci. USA 94, 3627-3632.
3. Akbar, A.N., Borthwick, N.J., Wickremasinghe, R.G., Panayoitidis, P., Pilling, D., Bofill, M., Krajewski, S., Reed, J.C., and Salmon, M. (1996). Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur. J. Immunol. 26, 294-299.
4. Brennan, P., Babbage, J.W., Burgering, B.M., Groner, B., Reif, K., and Cantrell, D.A. (1997). Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7, 679-689.
5. Cardone, M.H., Roy, N., Stennicke, H.R., Salvesen, G.S., Franke, T.F., Stanbridge, E., Frisch, S., and Reed, J.C. (1998). Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318-1321.
6. Collins, K.L., Chen, B.K., Kalams, S.A., Walker, B.D., and Baltimore, D. (1998). HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397-401.
7. Datta, S.R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M.E. (1997). Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241.
8. del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R., and Nunez, G. (1997). Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687-689.
9. Friedmann, M.C., Migone, T.S., Russell, J.M., and Leonard, W.J. (1996). Different interleukin 2 receptor beta-chain tyrosines couple at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc. Natl. Acad. Sci. USA 93, 2077-2082.
10. Fujii, H., Nakagawa, Y., Schindler, U., Kawahara, A., Mori, H., Gouilleux, F., Groner, B., Ihle, J.N., Minami, Y., Miyazaki, T., et al. (1995). Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. Proc. Natl. Acad. Sci. USA 92, 5482-5486.
11. Fujii, H., Ogasawara, K., Otsuka, H., Suzuki, M., Yamamura, K.I., Yokochi, T., Miyazaki, T., Suzuki, H., Mak, T.W., Taki, S., and Taniguchi, T. (1998). Functional dissection of the cytoplasmic subrogions of the IL-2 receptor βc chain in primary lymphocyte populations. EMBO J. 17, 6551-6557.
12. Hatakeyama, M., Mori, H., Doi, T., and Taniguchi, T. (1989). A restricted region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand and internalization. Cell 59, 837-845.
13. Hatakeyama, M., Kono, T., Kobayashi, N., Kawahara, A., Levin, S.D., Perlmutter, R.M., and Taniguchi, T. (1991). Interaction of the IL-2 receptor with the src-family kinase p56lck: Identification of novel intermolecular association. Science 252, 1523-1528.
14. Hawley, R.G., Lieu, F.H., Fong, A.Z., and Hawley, T.S. (1994). Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1, 136-138.
15. Ihle, J.N., Witthuhn, B.A., Quelle, F.W., Yamamoto, K., and Silvennoinen, O. (1995). Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13, 369-398.
16. Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.L., Schroter, M., Burns, K., Mattmann, C., et al. (1997). Inhibition of death receptor signals by cellular FLIP. Nature 388, 190-195.
17. Imada, K., Bloom, E.T., Nakajima, H., Horvath-Arcidiacono, J.A., Udy, G.B., Davey, H.W., and Leonard, W.J. (1998). Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J. Exp. Med. 188, 2067-2074.
18. Johnston, J.A., Bacon, C.M., Finbloom, D.S., Rees, R.C., Kaplan, D., Shibuya, K., Ortaldo, J.R., Gupta, S., Chen, Y.Q., Giri, J.D., et al. (1995). Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc. Natl. Acad. Sci. USA 92, 8705-8709.
19. Keegan, A.D., Nelms, K., White, M., Wang, L.M., Pierce, J.H., and Paul, W.E. (1994). An IL-4 receptor region containing an insulin receptor motif is important for IL-4 mediated IRS-1 phosphorylation and cell growth. Cell 76, 811-820.
20. Khoruts, A., Mondino, A., Pape, K.A., Reiner, S.L., and Jenkins, M.K. (1998). A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J. Exp. Med. 187, 225-236.
21. Kundig, T.M., Schorle, H., Bachmann, M.F., Hengartner, H., Zinkernagel, R.M., and Horak, I. (1993). Immune responses in interleukin-2-deficient mice. Science 262, 1059-1061.
22. Lenardo, M.J. (1991). Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353, 858-861.
23. Leonard, W.J. (1996). The molecular basis of X-linked severe combined immunodeficiency: Defective cytokine receptor signaling. Annu. Rev. Med. 47, 229-239.
24. Leonard, W.J., and O'Shea, J.J. (1998). Jaks and STATs: Biological implications. Annu. Rev. Immunol. 76, 293-322.
25. Lord, J.D., McIntosh, B.C., Greenberg, P.D., and Nelson, B.H. (1998). The interleukin-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adaptor molecule shc. J. Immunol. 161, 4627-4633.
26. Miyazaki, T., Kawahara, A., Fujii, H., Nakagawa, Y., Minami, Y., Liu, Z.J., Oishi, I., Silvennoinen, O., Witthuhn, B.A., Ihle, J.N., et al. (1994). Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266, 1045-1047.
27. Miyazaki, T., Liu, Z.J., Kawahara, A., Minami, Y., Yamada, K., Tsujimoto, Y., Barsoumian, E.L., Permutter, R.M., and Taniguchi, T. (1995). Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81, 223-231.
28. Miyazaki, T., Takaoka, A., Nogueira, L., Dikic, I., Fujii, H., Tsujino, S., Mitani, Y., Maeda, M., Schlessinger, J., and Taniguchi, T. (1998). Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway. Genes Dev. 12, 770-775.
29. Moriggl, R., Gouilleux-Gruart, V., Jahne, R., Brechold, S., Gratmann, C., Liu, X., Hennighausen, L., Sotiropoulos, A., Groner, B., and Gouilleux, F. (1996). Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol. Cell. Biol. 16, 5691-5700.
30. Moriggl, R., Topham, D.J., Teglund, S., Sexl, V., McKay, C., Wang, D., Hoffmeyer, A., van Deursen, J., Sangster, M.Y., Bunting, K.D., et al. (1999). Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10, 249-259.
31. Nabholz, M., Soldiani, E., Sperisen, P., Pla, M., Wang, S.M., MacDonald, H.R., Reichenbach, P., Beerman, F., and Bucher, P. (1995). The cis-acting elements controlling mouse IL-2R alpha transcription. Immunobiology 193, 259-262.
32. Nakajima, H., Liu, X.W., Wynshaw-Boris, A., Rosenthal, L.A., Imada, K., Finbloom, D.S., Hennighausen, L., and Leonard, W.J. (1997). An indirect effect of Stat5a in IL-2-induced proliferation: A critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity 7, 691-701.
33. Nelms, K., Keegan, A.D., Zamorano, J., Ryan, J.J., and Paul, W.E. (1999). The IL-4 receptor: Signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17, 701-738.
34. Pear, W.S., Nolan, G.P., Scott, M.L., and Baltimore, D. (1993). Production of high-liter helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396.
35. Ravichandran, K.S., Igras, V., Shoelson, S.E., Fesik, S.W., and Burakoff, S.J. (1996). Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. Proc. Natl. Acad. Sci. USA 93, 5275-5280.
36. Refaeli, Y., Van Parijs, L., London, C.A., Tschopp, J., and Abbas, A.K. (1998). Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8, 615-623.
37. Russell, S.M., Johnston, J.A., Noguchi, M., Kawamura, M., Bacon, C.M., Friedmann, M., Berg, M., McVicar, D.W., Witthuhn, B.A., Silvennoinen, O., et al. (1994). Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: Implications for XSCID and XCID. Science 266, 1042-1045.
38. Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A.C., and Horak, I. (1993). Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253-261.
39. Smith, K.A. (1988). Interleukin-2: Inception, impact, and implications. Science 240, 1169-1176.
40. Suzuki, H., Kunding, T.M., Furlonger, C., Wakeman, A., Timms, E., Matsuyama, T., Schimtts, T., Simard, J., Ohashi, P.S., Greisser, H., et al. (1995). Deregulated T cell activation and autoimmunity in mice lacking IL-2 receptor beta. Science 268, 1472-1476.
41. Taniguchi, T. (1995). Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268, 251-255.
42. Taniguchi, T., and Minami, Y. (1993). The IL-2/IL-2 receptor system: A current overview. Cell 73, 5-8.
43. Van Parijs, L., and Abbas, A.K. (1996). Role of Fas-mediated cell death in the regulation of immune responses. Curr. Opin. Immunol. 8, 355-361.
44. Van Parijs, L., and Abbas, A.K. (1998). Homeostasis and self-tolerance in the immune system: Turning lymphocytes off. Science 280, 243-248.
45. Van Parijs, L., Biuckians, A., Ibragimov, A., Alt, F.W., Willerford, D.M., and Abbas, A.K. (1997). Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor. J. Immunol. 158, 3738-3745.
46. Wang, L.M., Myers, M.G., Jr., Sun, X.J., Aaronson, S.A., White, M., and Pierce, J.H. (1993). IRS-1: Essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science 267, 1591-1594.
47. Wang, D., Stravopodis, D., Teglund, S., Kitazawa, J., and Ihle, J. (1996a). Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol. 16, 6141-6148.
48. Wang, R., Rogers, A.M., Rush, B.J., and Russell, J.H. (1996b). Induction of sensitivity to activation-induced death in primary CD4+ cells: A role for interleukin-2 in the negative regulation of responses by mature CD4+ T cells. Eur. J. Immunol. 26, 2263-2270.
49. Willerford, D.M., Chen, J., Ferry, J.A., Davidson, L., Ma, A., and Alt, F.W. (1995). Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521-530.
50. Zheng, L., Trageser, C.L., Willerford, D.M., and Lenardo, M.J. (1998). T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death. J. Immunol. 160, 763-769.